Back to Search
ROBERT NACLERIO, MD
MD
Otolaryngology Physician
NPI: 1356406185Individual
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
D25122(MD)036088518(IL)
Clinical Trials (7)
7
Linked Trials
0
Recruiting
5
With Results
Vitamin D Plus Fluticasone Propionate
NCT01103934COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
NasoNeb Delivery of an Intranasal Steroid
NCT01270256COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen
NCT00791973COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Intranasal Steroids and Oxymetazoline in Allergic Rhinitis
NCT00584987COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Xolair in Patients With Chronic Sinusitis
NCT00117611COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms
NCT01007253COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Intranasal Steroids and the Nasal Ocular Response
NCT00473915COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis.
PMID 24574125·Int Forum Allergy Rhinol·2014
2-rct
Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
PMID 23406601·Am J Rhinol Allergy·2013
2-rct
Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
PMID 21377716·J Allergy Clin Immunol·2011
2-rct
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis.
PMID 21038023·Rhinology·2010
2-rct
Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
PMID 19428097·J Allergy Clin Immunol·2009
2-rct
Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20).
PMID 11821764·Otolaryngol Head Neck Surg·2002
4-observational
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
PMID 11529281·Eur Respir J·2001
3-trial
Prevalence and relationship between allergic diseases and infectious diseases.
PMID 11321129·J Microbiol Immunol Infect·2001
8-other
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
PMID 11496232·J Allergy Clin Immunol·2001
3-trial
Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis.
PMID 18241703·Otolaryngol Head Neck Surg·2008
1-meta
Observations on the ability of the nose to warm and humidify inspired air.
PMID 17708456·Rhinology·2007
6-review
A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone.
PMID 12601318·Otolaryngol Head Neck Surg·2003
3-trial
Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis.
PMID 18585770·J Allergy Clin Immunol·2008
8-other
A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q.
PMID 18622306·Laryngoscope·2008
4-observational
Effect of changing airway pressure on the ability of the human nose to warm and humidify air.
PMID 18700424·Ann Otol Rhinol Laryngol·2008
4-observational
Otolaryngology (urban) legend: the more programs to which you apply, the better the chances of matching.
PMID 18936346·Arch Otolaryngol Head Neck Surg·2008
8-other
Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis.
PMID 18426137·Ann Allergy Asthma Immunol·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 180 HARVESTER DR STE 110
BURR RIDGE, IL 60527 - Phone
- (773) 834-4064
Quick Facts
- NPI
- 1356406185
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile